(Reuters) - A U.S. jury rejected GlaxoSmithKline’s antitrust claims against Abbott Laboratories over allegations of unfair HIV drug pricing, after Britain’s biggest drugmaker had asked for hundreds of millions in damages.
(Reuters) - A U.S. jury rejected GlaxoSmithKline’s antitrust claims against Abbott Laboratories over allegations of unfair HIV drug pricing, after Britain’s biggest drugmaker had asked for hundreds of millions in damages.
